✦ LIBER ✦

Neurogenic orthostatic hypotension: New prospects in treatment

✍ Scribed by Horacio Kaufmann

Publisher: Springer
Year: 2008
Tongue: English
Weight: 73 KB
Volume: 18
Category: Article
ISSN: 0959-9851
DOI: 10.1007/s10286-008-1006-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

L-dihydroxyphenylserine (Droxidopa): a n

L-dihydroxyphenylserine (Droxidopa): a new therapy for neurogenic orthostatic hypotension

✍ Horacio Kaufmann 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 271 KB

Patterns of plasma levels of catechols i

Patterns of plasma levels of catechols in neurogenic orthostatic hypotension

✍ Dr David S. Goldstein; Ronald J. Polinsky; Moshe Garty; David Robertson; Robert 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 592 KB

Pyridostigmine in the treatment of ortho

Pyridostigmine in the treatment of orthostatic hypotension

✍ Jean-Michel Senard 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 134 KB

In response: Pyridostigmine in the treat

In response: Pyridostigmine in the treatment of orthostatic hypotension

✍ Paola Sandroni; on behalf of all authors 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 100 KB

L-dihydroxyphenylserine (Droxidopa) in t

L-dihydroxyphenylserine (Droxidopa) in the treatment of orthostatic hypotension

✍ Christopher J. Mathias 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 172 KB

Nonpharmacological treatment, fludrocort

Nonpharmacological treatment, fludrocortisone, and domperidone for orthostatic hypotension in Parkinson's disease

✍ Kerrie L. Schoffer; Robert D. Henderson; Karen O'Maley; John D. O'Sullivan 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

## Abstract There is limited evidence for the treatment of orthostatic hypotension in idiopathic Parkinson's disease. The objective of this study was to determine the efficacy of three treatments (nonpharmacological therapy, fludrocortisone, and domperidone). Phase I assessed the compliance, safety